FDA says Zimmer's spinal implant meets study goal
FDA reviewers said Zimmer Holdings' Dynesys implant is as effective as the company's Silhouette implant in treating spinal problems, but raised questions about possible influence on the study. A company spokesman did not immediately comment on the issue. An FDA panel is set to meet Wednesday to discuss the product.
Google | 11/02
This story published in AdvaMed SmartBrief on 11/03/2009
More from SmartBrief:
Orthopedic implant maker to publicly offer $1B in senior notes
Friday, November 13, 2009
Tax proposal, recession threaten orthopedic sector's growth
Wednesday, October 14, 2009
Zimmer stops operation of device facility in Indiana due to fire
Friday, September 4, 2009
Get stories like these delivered daily for FREE:
|
AdvaMed SmartBrief
Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more |
|